Evaluation of new IPSS-Molecular model and comparison of different prognostic systems in patients with myelodysplastic syndrome

A risk-adapted treatment strategy is of crucial importance in patients with myelodysplastic syndromes (MDS). Previous risk prognostic scoring systems did not integrate molecular abnormalities. The new IPSS-Molecular (IPSS-M) model, combing genomic profiling with hematologic and cytogenetic parameter...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Jiale, Gu, Yan, Wei, Yanhui, Wang, Xuee, Wang, Peixuan, Song, Chunhua, Ge, Zheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10400062/
https://www.ncbi.nlm.nih.gov/pubmed/37546714
http://dx.doi.org/10.1097/BS9.0000000000000166

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10400062/
https://www.ncbi.nlm.nih.gov/pubmed/37546714
http://dx.doi.org/10.1097/BS9.0000000000000166

Ejemplares similares